2004N-0330 - Joint Meeting of the Psychopharmacologic Drugs Advisory Committee and the Pediatric Advisory Committee
FDA Comment Number : EC19
Submitter : Dr. David Healy Date & Time: 09/03/2004 06:09:44
Organization : Cardiff University
Health Professional
Category :
Issue Areas/Comments
GENERAL
GENERAL
Recently, Pfizer have posted on the FDA website announcing the forthcoming PDAC hearings on September 13th an ad hominem attack on me. This was apparently cleared by Daniel Troy, chief counsel to the FDA before posting. The attached documents constitute a preliminary response which I would hope to supplement at the hearings on the 13th.